ACADIA Pharmaceuticals Inc.
ACAD
$25.33
$0.803.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.44% | -86.79% | 338.71% | -1.87% | 101.69% |
| Total Depreciation and Amortization | -0.54% | -43.40% | 102.88% | -0.04% | -53.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.21% | 106.67% | -693.08% | 70.54% | 5.92% |
| Change in Net Operating Assets | 298.10% | -135.90% | 574.39% | 118.21% | -313.51% |
| Cash from Operations | 214.70% | -49.67% | -36.15% | 152.85% | -13.98% |
| Capital Expenditure | -- | -- | -547.14% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.34% | -418.77% | 70.98% | -46.62% | -300.26% |
| Cash from Investing | 65.10% | -201.55% | 248.14% | -46.74% | -300.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 768.12% | -6.65% | 634.70% | -92.48% | 241.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 768.12% | -6.65% | 634.70% | -92.48% | 241.80% |
| Foreign Exchange rate Adjustments | 580.00% | 91.67% | -42.86% | -1,500.00% | -40.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 135.96% | -161.96% | 966.16% | 31.24% | -271.62% |